4H4-27673-26053
3 vaccinations
1 coded response
16 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 275 / NC
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Registered in v-safe
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-04
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body achesAdult check-in
- 2021-03-20
-
2021-03-26
Dose 2 — Pfizer-BioNTech
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-11
- 2021-04-16
- 2021-04-25
- 2021-04-30
- 2021-05-07
- 2021-06-25
- 2021-09-26
-
2021-10-06
Dose 3 — Pfizer-BioNTech
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body achesAdult check-in
-
2022-10-08
Survey response — 12 months, dose 3MedDRA: Brain fog, Chills, Fatigue, Pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fever, chills, body aches, extreme fatigue, brain fog, joint pain, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-10-08
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-26 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-08 | Unsuccessful |
Free text
Release 12 — 12 months, dose 3
Symptoms: Fever, chills, body aches, extreme fatigue, brain fog, joint pain, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release